Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NeuClone Discloses Details of its Fifth Product: A Biosimilar Candidate for Prolia/XGEVA (Denosumab)

prnasiaJanuary 09, 2018

Tag: NeuClone Pty , Pharmaceuticals

PharmaSources Customer Service